Cargando…

Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) has developed substantially since its inception. Improvements in valve design, valve deployment technologies, preprocedural imaging and increased operator experience have led to a gradual decline in length of hospitalisation after TAVR. Despite these adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzella, Anthony J, Arora, Sameer, Hendrickson, Michael J, Sanders, Mason, Vavalle, John P, Gehi, Anil K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353545/
https://www.ncbi.nlm.nih.gov/pubmed/34386266
http://dx.doi.org/10.15420/cfr.2021.05
_version_ 1783736428230868992
author Mazzella, Anthony J
Arora, Sameer
Hendrickson, Michael J
Sanders, Mason
Vavalle, John P
Gehi, Anil K
author_facet Mazzella, Anthony J
Arora, Sameer
Hendrickson, Michael J
Sanders, Mason
Vavalle, John P
Gehi, Anil K
author_sort Mazzella, Anthony J
collection PubMed
description Transcatheter aortic valve replacement (TAVR) has developed substantially since its inception. Improvements in valve design, valve deployment technologies, preprocedural imaging and increased operator experience have led to a gradual decline in length of hospitalisation after TAVR. Despite these advances, the need for permanent pacemaker implantation for post-TAVR high-degree atrioventricular block (HAVB) has persisted and has well-established risk factors which can be used to identify patients who are at high risk and advise them accordingly. While most HAVB occurs within 48 hours of the procedure, there is a growing number of patients developing HAVB after initial hospitalisation for TAVR due to the trend for early discharge from hospital. Several observation and management strategies have been proposed. This article reviews major known risk factors for HAVB after TAVR, discusses trends in the timing of HAVB after TAVR and reviews some management strategies for observing transient HAVB after TAVR.
format Online
Article
Text
id pubmed-8353545
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-83535452021-08-11 Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement Mazzella, Anthony J Arora, Sameer Hendrickson, Michael J Sanders, Mason Vavalle, John P Gehi, Anil K Card Fail Rev Clinical Practice Transcatheter aortic valve replacement (TAVR) has developed substantially since its inception. Improvements in valve design, valve deployment technologies, preprocedural imaging and increased operator experience have led to a gradual decline in length of hospitalisation after TAVR. Despite these advances, the need for permanent pacemaker implantation for post-TAVR high-degree atrioventricular block (HAVB) has persisted and has well-established risk factors which can be used to identify patients who are at high risk and advise them accordingly. While most HAVB occurs within 48 hours of the procedure, there is a growing number of patients developing HAVB after initial hospitalisation for TAVR due to the trend for early discharge from hospital. Several observation and management strategies have been proposed. This article reviews major known risk factors for HAVB after TAVR, discusses trends in the timing of HAVB after TAVR and reviews some management strategies for observing transient HAVB after TAVR. Radcliffe Cardiology 2021-07-27 /pmc/articles/PMC8353545/ /pubmed/34386266 http://dx.doi.org/10.15420/cfr.2021.05 Text en Copyright © 2021, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Clinical Practice
Mazzella, Anthony J
Arora, Sameer
Hendrickson, Michael J
Sanders, Mason
Vavalle, John P
Gehi, Anil K
Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement
title Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement
title_full Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement
title_fullStr Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement
title_full_unstemmed Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement
title_short Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement
title_sort evaluation and management of heart block after transcatheter aortic valve replacement
topic Clinical Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353545/
https://www.ncbi.nlm.nih.gov/pubmed/34386266
http://dx.doi.org/10.15420/cfr.2021.05
work_keys_str_mv AT mazzellaanthonyj evaluationandmanagementofheartblockaftertranscatheteraorticvalvereplacement
AT arorasameer evaluationandmanagementofheartblockaftertranscatheteraorticvalvereplacement
AT hendricksonmichaelj evaluationandmanagementofheartblockaftertranscatheteraorticvalvereplacement
AT sandersmason evaluationandmanagementofheartblockaftertranscatheteraorticvalvereplacement
AT vavallejohnp evaluationandmanagementofheartblockaftertranscatheteraorticvalvereplacement
AT gehianilk evaluationandmanagementofheartblockaftertranscatheteraorticvalvereplacement